[go: up one dir, main page]

FI950044L - Förfaranden för förhindrande av sönderfall hos protein C - Google Patents

Förfaranden för förhindrande av sönderfall hos protein C Download PDF

Info

Publication number
FI950044L
FI950044L FI950044A FI950044A FI950044L FI 950044 L FI950044 L FI 950044L FI 950044 A FI950044 A FI 950044A FI 950044 A FI950044 A FI 950044A FI 950044 L FI950044 L FI 950044L
Authority
FI
Finland
Prior art keywords
degradation
inhibiting protein
inhibiting
protein
Prior art date
Application number
FI950044A
Other languages
English (en)
Finnish (fi)
Other versions
FI950044A0 (sv
FI115635B (sv
Inventor
Jr Walter Francis Prouty
Josephine Secnik
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22650141&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI950044(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI950044A0 publication Critical patent/FI950044A0/sv
Publication of FI950044L publication Critical patent/FI950044L/sv
Application granted granted Critical
Publication of FI115635B publication Critical patent/FI115635B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4866Protein C (3.4.21.69)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6464Protein C (3.4.21.69)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI950044A 1994-01-05 1995-01-04 Förfaranden för förhindrande av sönderfall hos protein C FI115635B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17783294A 1994-01-05 1994-01-05
US17783294 1994-01-05

Publications (3)

Publication Number Publication Date
FI950044A0 FI950044A0 (sv) 1995-01-04
FI950044L true FI950044L (sv) 1995-07-06
FI115635B FI115635B (sv) 2005-06-15

Family

ID=22650141

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950044A FI115635B (sv) 1994-01-05 1995-01-04 Förfaranden för förhindrande av sönderfall hos protein C

Country Status (29)

Country Link
EP (2) EP1087011A3 (sv)
JP (1) JP3778588B2 (sv)
KR (1) KR950032287A (sv)
CN (1) CN1109891A (sv)
AT (1) ATE201045T1 (sv)
AU (1) AU1003195A (sv)
BR (1) BR9500017A (sv)
CA (1) CA2139468C (sv)
CO (1) CO4600680A1 (sv)
CZ (1) CZ1395A3 (sv)
DE (2) DE10299053I2 (sv)
DK (1) DK0662513T3 (sv)
ES (1) ES2156190T3 (sv)
FI (1) FI115635B (sv)
GR (1) GR3036277T3 (sv)
HU (1) HUT70465A (sv)
IL (1) IL112236A (sv)
LU (2) LU90992I2 (sv)
NL (1) NL300108I2 (sv)
NO (2) NO320157B1 (sv)
NZ (1) NZ270271A (sv)
PE (1) PE43995A1 (sv)
PL (1) PL180703B1 (sv)
PT (1) PT662513E (sv)
RU (1) RU2167936C2 (sv)
SI (1) SI0662513T1 (sv)
UA (1) UA39178C2 (sv)
YU (1) YU295A (sv)
ZA (1) ZA9514B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1557463A1 (en) * 1997-04-28 2005-07-27 Eli Lilly & Company Improved methods for processing activated protein C
EA004881B1 (ru) * 1997-04-28 2004-08-26 Эли Лилли Энд Компани Лиофилизированные композиции на основе рекомбинантного человеческого активированного протеина с и их применение
US6630137B1 (en) 1997-04-28 2003-10-07 Eli Lilly And Company Activated protein C formulations
US7204981B2 (en) 2000-03-28 2007-04-17 Eli Lilly And Company Methods of treating diseases with activated protein C
CA2410567A1 (en) 2000-05-24 2001-11-29 Eli Lilly And Company Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c

Also Published As

Publication number Publication date
IL112236A (en) 1999-12-31
DK0662513T3 (da) 2001-05-28
ATE201045T1 (de) 2001-05-15
NO2006006I1 (no) 2006-05-15
IL112236A0 (en) 1995-03-30
DE10299053I1 (de) 2003-05-22
JP3778588B2 (ja) 2006-05-24
FI950044A0 (sv) 1995-01-04
CA2139468C (en) 2007-08-21
ZA9514B (en) 1996-07-03
SI0662513T1 (en) 2001-10-31
RU95100178A (ru) 1997-03-27
KR950032287A (ko) 1995-12-20
PL306671A1 (en) 1995-07-10
CA2139468A1 (en) 1995-07-06
EP1087011A3 (en) 2002-02-06
NO320157B1 (no) 2005-11-07
LU90993I2 (fr) 2003-02-18
JPH07206704A (ja) 1995-08-08
EP0662513B1 (en) 2001-05-09
NO950018L (no) 1995-07-06
UA39178C2 (uk) 2001-06-15
EP0662513A1 (en) 1995-07-12
PT662513E (pt) 2001-08-30
DE10299053I2 (de) 2004-04-01
FI115635B (sv) 2005-06-15
PL180703B1 (pl) 2001-03-30
EP1087011A2 (en) 2001-03-28
GR3036277T3 (en) 2001-10-31
CO4600680A1 (es) 1998-05-08
BR9500017A (pt) 1995-10-03
CZ1395A3 (en) 1995-07-12
RU2167936C2 (ru) 2001-05-27
HU9500021D0 (en) 1995-03-28
LU90992I2 (fr) 2003-02-18
PE43995A1 (es) 1995-12-15
DE69520844D1 (de) 2001-06-13
AU1003195A (en) 1995-07-13
NL300108I1 (nl) 2003-02-03
CN1109891A (zh) 1995-10-11
YU295A (sh) 1997-09-30
NO950018D0 (no) 1995-01-03
HUT70465A (en) 1995-10-30
DE69520844T2 (de) 2001-11-08
NZ270271A (en) 1996-07-26
NL300108I2 (nl) 2003-06-02
ES2156190T3 (es) 2001-06-16

Similar Documents

Publication Publication Date Title
DE69534965D1 (de) Abscheidungsverfahren
FI951596L (sv) Förfarande för erhållande av 10-desacetylbakkatin III
DE69510305D1 (de) Fördersystem
FI954423L (sv) Förfarande för rening av taxoider
DE69511811D1 (de) Förderanlage
BR9500653A (pt) Método de combustão
FI943196L (sv) Mottagningsförfarande och mottagare
FI970670L (sv) Förbränningsförfarande
KR970001365A (ko) 알킬하이드로겐클로로실란의 제조방법
NO970726D0 (no) Test-fremgangsmåte
LV11745A (lv) Metode nepartrauktai misas varisanai
EP1006783A4 (en) Shoot meristem specific promoter sequences
FI20050181L (sv) Förfarande för att framställa 21-klorkortikosteroider
FI955800L (sv) Metod att framställa aminoalkylguanidiner
ID17723A (id) Senyawa untuk pengobatan
FI964001L (sv) Förfarande för framställning av 7-trialkylsilylbackatin III
BR9609671A (pt) Amino uracilas substituídas
FI945877L (sv) Förfarande för att producera protein C
FI963018L (sv) Förfarande för framställning av gammapyroner
ID18300A (id) Metoda penemperan
DE59600552D1 (de) Spannvorrichtung
FI950044L (sv) Förfaranden för förhindrande av sönderfall hos protein C
DE69523504D1 (de) Ernte-Apparat
FI971675L (sv) Förfarande för att inhibera tillstånd som associeras med bradykinin
EE9400450A (et) Meetod detailide töötlemiseks

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 115635

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: CARDIOME PHARMA CORP.

Free format text: CARDIOME PHARMA CORP.

MM Patent lapsed